вторник, 30 ноября 2010 г.

Cediranib

Name: 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline
Alternate Name/Synonyms: AZD2171, Recentin
CAS Number: 288383-20-0
Molecular Formula: C₂₅H₂₇FN₄O₃
Molecular Weight: 450.51
Description: Cediranib (AZD2171) is a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, c-KIT, and platelet-derived growth factor receptors. Studies show cediranib to be generally well tolerated as monotherapy at doses of 45 mg/d or less.

Комментариев нет:

Отправить комментарий

Ярлыки

AB1010 (1) ABT-869 (1) AG-013736 (1) ALK-kinase (1) AMG-706 (1) AP24534 (1) AV-951 (1) AZD-0530 (1) AZD2171 (2) Afatinib (2) Apatinib (1) Armala (1) BAY 73-4506 (1) BIBW 2992 (1) BMS-540215 (2) Bafenitib (1) Bafetinib (2) Brivanib (2) CEP-701 (1) CHIR258 (1) CP690550 (1) Cediranib (2) Crizotinib (1) Dasatinib (2) Dovitinib (1) Erlotinib (1) Foretinib (1) Gefinitib (1) Gefitinib (2) Gold reagent (1) HKI 272 (1) INNO-406 (2) Icotinib (1) Iressa (1) MLN 518 (1) Masitinib (1) Mubritinib (2) NS-187 (2) Nexavar (2) OSI-774 (1) PF-02341066 (1) PHA-739358 (1) Palladia (1) Pazopanib (2) Pelitinib (1) Ponatinib (1) Recentin (2) Regorafenib (1) Ruxolitinib (1) SKI-606 (2) Saracatinib (2) Silimitasertib (1) Sorafenib (2) Sorafenib tosylate (1) Sprycel (2) Sunitinib (2) Sunitinib Malate (2) Sutent (2) TKI-258 (1) Tarceva (2) Tasocitinib (1) Tivozanib (1) Tovok (2) Vatalanib (1) Votrient (2) YN968D1 (1) ZD6474 (1) axinitib (1) bosutinib (2) canertinib (1) danusertib (1) gleevec (1) imatinib (1) lapatinib (2) lestaurtinib (1) linifanib (1) nilotinib (1) pyrazole (1) sc-202353 (1) targeted agents (1) tasigna (1) toceranib (1) tykerb (2) tyverb (1) vandetanib (1) zactima (1) Бринатиниб (1) Гефитиниб (1) Кризотиниб (1) Маситиниб (1) Сунитиниб (2) Тарцева (2) Цедираниб (1) Эрлотиниб (2) акситиниб (1) ваталаниб (1) гливек (1) дазатиниб (2) данусертиб (1) зактима (1) икотиниб (1) карнетиниб (1) куизартиниб (1) лапатиниб (1) лекарства (1) лекарство (1) линифаниб (1) нексавар (1) понатиниб (1) руксолитиниб (1) сорафениб (1) спрайсел (2) сутент (1) тайверб (1) тандуниб (1) 凡德他尼 (1) 尼罗替尼 (1) 阿西替尼 (1)